{"transactions":[{"id":2596,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":1898,"kind":"person","name":"O'Connor Padraig Andrew","position":1,"cik":"0002098740","reported_name":"O'Connor Padraig Andrew","relationship":{"officer":true,"officer_title":"EVP, Global Operations"}}],"security":"Restricted Stock Units","published_at":"2026-09-03T20:34:44.000Z","date":"2026-09-02","kind":"exercise","planned":false,"acquired":false,"shares":1171,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on September 2, 2026, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on September 2, 2026, the first anniversary of the date of grant."}],"balance_after":3516,"derivative":{"expiration_date":"2029-09-02","underlying":"Common Stock","underlying_shares":1171},"source":{"system":"sec-edgar","filing":"0001225208-26-007620","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2098740/000122520826007620/doc4.xml","form_type":"4"}},{"id":2595,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":1898,"kind":"person","name":"O'Connor Padraig Andrew","position":1,"cik":"0002098740","reported_name":"O'Connor Padraig Andrew","relationship":{"officer":true,"officer_title":"EVP, Global Operations"}}],"security":"Common Stock","published_at":"2026-09-03T20:34:44.000Z","date":"2026-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":567,"price":48.37,"value":27425.79,"ownership":{"direct":true},"balance_after":7892,"source":{"system":"sec-edgar","filing":"0001225208-26-007620","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2098740/000122520826007620/doc4.xml","form_type":"4"}},{"id":2594,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":1898,"kind":"person","name":"O'Connor Padraig Andrew","position":1,"cik":"0002098740","reported_name":"O'Connor Padraig Andrew","relationship":{"officer":true,"officer_title":"EVP, Global Operations"}}],"security":"Common Stock","published_at":"2026-09-03T20:34:44.000Z","date":"2026-09-02","kind":"exercise","planned":false,"acquired":true,"shares":1171,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":8459,"source":{"system":"sec-edgar","filing":"0001225208-26-007620","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2098740/000122520826007620/doc4.xml","form_type":"4"}},{"id":794580,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":1898,"kind":"person","name":"O'Connor Padraig Andrew","position":1,"cik":"0002098740","reported_name":"O'Connor Padraig Andrew","relationship":{"officer":true,"officer_title":"EVP, Global Operations"}}],"security":"Restricted Stock Units","published_at":"2026-05-04T21:30:22.000Z","date":"2026-05-02","kind":"exercise","planned":false,"acquired":false,"shares":1802,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 2, 2023, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 2, 2023, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"expiration_date":"2026-05-02","underlying":"Common Stock","underlying_shares":1802},"source":{"system":"sec-edgar","filing":"0001225208-26-004897","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826004897/doc4.xml","form_type":"4"}},{"id":794579,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":1898,"kind":"person","name":"O'Connor Padraig Andrew","position":1,"cik":"0002098740","reported_name":"O'Connor Padraig Andrew","relationship":{"officer":true,"officer_title":"EVP, Global Operations"}}],"security":"Common Stock","published_at":"2026-05-04T21:30:22.000Z","date":"2026-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":872,"price":56.5,"value":49268.0,"ownership":{"direct":true},"balance_after":7024,"source":{"system":"sec-edgar","filing":"0001225208-26-004897","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826004897/doc4.xml","form_type":"4"}},{"id":794578,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":1898,"kind":"person","name":"O'Connor Padraig Andrew","position":1,"cik":"0002098740","reported_name":"O'Connor Padraig Andrew","relationship":{"officer":true,"officer_title":"EVP, Global Operations"}}],"security":"Common Stock","published_at":"2026-05-04T21:30:22.000Z","date":"2026-05-02","kind":"exercise","planned":false,"acquired":true,"shares":1802,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":7896,"source":{"system":"sec-edgar","filing":"0001225208-26-004897","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826004897/doc4.xml","form_type":"4"}},{"id":898710,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":1898,"kind":"person","name":"O'Connor Padraig Andrew","position":1,"cik":"0002098740","reported_name":"O'Connor Padraig Andrew","relationship":{"officer":true,"officer_title":"EVP, Global Operations"}}],"security":"Restricted Stock Units","published_at":"2026-02-18T22:58:55.000Z","date":"2026-02-16","kind":"exercise","planned":false,"acquired":false,"shares":905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"expiration_date":"2026-02-16","underlying":"Common Stock","underlying_shares":905},"source":{"system":"sec-edgar","filing":"0001225208-26-002137","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002137/doc4.xml","form_type":"4"}},{"id":898709,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":1898,"kind":"person","name":"O'Connor Padraig Andrew","position":1,"cik":"0002098740","reported_name":"O'Connor Padraig Andrew","relationship":{"officer":true,"officer_title":"EVP, Global Operations"}}],"security":"Restricted Stock Units","published_at":"2026-02-18T22:58:55.000Z","date":"2026-02-14","kind":"exercise","planned":false,"acquired":false,"shares":1190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant."}],"balance_after":1190,"derivative":{"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":1190},"source":{"system":"sec-edgar","filing":"0001225208-26-002137","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002137/doc4.xml","form_type":"4"}},{"id":898708,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":1898,"kind":"person","name":"O'Connor Padraig Andrew","position":1,"cik":"0002098740","reported_name":"O'Connor Padraig Andrew","relationship":{"officer":true,"officer_title":"EVP, Global Operations"}}],"security":"Restricted Stock Units","published_at":"2026-02-18T22:58:55.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant."}],"balance_after":1502,"derivative":{"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001225208-26-002137","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002137/doc4.xml","form_type":"4"}},{"id":898707,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":1898,"kind":"person","name":"O'Connor Padraig Andrew","position":1,"cik":"0002098740","reported_name":"O'Connor Padraig Andrew","relationship":{"officer":true,"officer_title":"EVP, Global Operations"}}],"security":"Common Stock","published_at":"2026-02-18T22:58:55.000Z","date":"2026-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":339,"price":74.73,"value":25333.47,"ownership":{"direct":true},"balance_after":6094,"source":{"system":"sec-edgar","filing":"0001225208-26-002137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002137/doc4.xml","form_type":"4"}},{"id":898706,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":1898,"kind":"person","name":"O'Connor Padraig Andrew","position":1,"cik":"0002098740","reported_name":"O'Connor Padraig Andrew","relationship":{"officer":true,"officer_title":"EVP, Global Operations"}}],"security":"Common Stock","published_at":"2026-02-18T22:58:55.000Z","date":"2026-02-16","kind":"exercise","planned":false,"acquired":true,"shares":905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":6433,"source":{"system":"sec-edgar","filing":"0001225208-26-002137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002137/doc4.xml","form_type":"4"}},{"id":898705,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":1898,"kind":"person","name":"O'Connor Padraig Andrew","position":1,"cik":"0002098740","reported_name":"O'Connor Padraig Andrew","relationship":{"officer":true,"officer_title":"EVP, Global Operations"}}],"security":"Common Stock","published_at":"2026-02-18T22:58:55.000Z","date":"2026-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":449,"price":74.73,"value":33553.77,"ownership":{"direct":true},"balance_after":5528,"source":{"system":"sec-edgar","filing":"0001225208-26-002137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002137/doc4.xml","form_type":"4"}},{"id":898704,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":1898,"kind":"person","name":"O'Connor Padraig Andrew","position":1,"cik":"0002098740","reported_name":"O'Connor Padraig Andrew","relationship":{"officer":true,"officer_title":"EVP, Global Operations"}}],"security":"Common Stock","published_at":"2026-02-18T22:58:55.000Z","date":"2026-02-14","kind":"exercise","planned":false,"acquired":true,"shares":1190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":5977,"source":{"system":"sec-edgar","filing":"0001225208-26-002137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002137/doc4.xml","form_type":"4"}},{"id":898703,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":1898,"kind":"person","name":"O'Connor Padraig Andrew","position":1,"cik":"0002098740","reported_name":"O'Connor Padraig Andrew","relationship":{"officer":true,"officer_title":"EVP, Global Operations"}}],"security":"Common Stock","published_at":"2026-02-18T22:58:55.000Z","date":"2026-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":199,"price":74.73,"value":14871.27,"ownership":{"direct":true},"balance_after":4787,"source":{"system":"sec-edgar","filing":"0001225208-26-002137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002137/doc4.xml","form_type":"4"}},{"id":898702,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":1898,"kind":"person","name":"O'Connor Padraig Andrew","position":1,"cik":"0002098740","reported_name":"O'Connor Padraig Andrew","relationship":{"officer":true,"officer_title":"EVP, Global Operations"}}],"security":"Common Stock","published_at":"2026-02-18T22:58:55.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":4986,"source":{"system":"sec-edgar","filing":"0001225208-26-002137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002137/doc4.xml","form_type":"4"}},{"id":903217,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":1898,"kind":"person","name":"O'Connor Padraig Andrew","position":1,"cik":"0002098740","reported_name":"O'Connor Padraig Andrew","relationship":{"officer":true,"officer_title":"EVP, Global Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-18T00:07:52.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":11939,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant."}],"balance_after":11939,"derivative":{"exercise_price":74.12,"expiration_date":"2036-02-12","underlying":"Common Stock","underlying_shares":11939},"source":{"system":"sec-edgar","filing":"0001225208-26-002018","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002018/doc4.xml","form_type":"4"}},{"id":903216,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":1898,"kind":"person","name":"O'Connor Padraig Andrew","position":1,"cik":"0002098740","reported_name":"O'Connor Padraig Andrew","relationship":{"officer":true,"officer_title":"EVP, Global Operations"}}],"security":"Restricted Stock Units","published_at":"2026-02-18T00:07:52.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":5059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant."}],"balance_after":5059,"derivative":{"expiration_date":"2030-02-12","underlying":"Common Stock","underlying_shares":5059},"source":{"system":"sec-edgar","filing":"0001225208-26-002018","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002018/doc4.xml","form_type":"4"}},{"id":903215,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":1898,"kind":"person","name":"O'Connor Padraig Andrew","position":1,"cik":"0002098740","reported_name":"O'Connor Padraig Andrew","relationship":{"officer":true,"officer_title":"EVP, Global Operations"}}],"security":"Restricted Stock Units","published_at":"2026-02-18T00:07:52.000Z","date":"2026-02-12","kind":"exercise","planned":false,"acquired":false,"shares":1058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant."}],"balance_after":2116,"derivative":{"expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":1058},"source":{"system":"sec-edgar","filing":"0001225208-26-002018","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002018/doc4.xml","form_type":"4"}},{"id":903214,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":1898,"kind":"person","name":"O'Connor Padraig Andrew","position":1,"cik":"0002098740","reported_name":"O'Connor Padraig Andrew","relationship":{"officer":true,"officer_title":"EVP, Global Operations"}}],"security":"Common Stock","published_at":"2026-02-18T00:07:52.000Z","date":"2026-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":457,"price":74.12,"value":33872.84,"ownership":{"direct":true},"balance_after":4486,"source":{"system":"sec-edgar","filing":"0001225208-26-002018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002018/doc4.xml","form_type":"4"}},{"id":903213,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":1898,"kind":"person","name":"O'Connor Padraig Andrew","position":1,"cik":"0002098740","reported_name":"O'Connor Padraig Andrew","relationship":{"officer":true,"officer_title":"EVP, Global Operations"}}],"security":"Common Stock","published_at":"2026-02-18T00:07:52.000Z","date":"2026-02-12","kind":"exercise","planned":false,"acquired":true,"shares":1058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":4943,"source":{"system":"sec-edgar","filing":"0001225208-26-002018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002018/doc4.xml","form_type":"4"}}]}